U.S. FDA issues seven observations to Dr. Reddy’s biologics manufacturing facility in Hyderabad

How 1 sources are covering this

• The HinduLean L·2h ago

  U.S. FDA issues seven observations to Dr. Reddy’s biologics manufacturing facility in Hyderabad

  The company cited two previous inspections of the facility in October 2023 and September 2025 when the U.S. FDA had issued a Form 483 each with nine and five observations respectively

  Read at The Hindu →